Canada’s New Fentanyl Chief Confronts a Crisis Most Locals See as Trump-made
Kevin Brosseau is seeking to stem the flow of a deadly opioid not only to reverse U.S. tariffs but to end domestic drug deaths.
Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients
Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: ...